NO982078L - FremgangsmÕte for beskyttelse av et donorhjerte for transplantering samt anvendelse av en N-aryl-piperazinalkanamidforbindelse for dette formÕl - Google Patents
FremgangsmÕte for beskyttelse av et donorhjerte for transplantering samt anvendelse av en N-aryl-piperazinalkanamidforbindelse for dette formÕlInfo
- Publication number
- NO982078L NO982078L NO982078A NO982078A NO982078L NO 982078 L NO982078 L NO 982078L NO 982078 A NO982078 A NO 982078A NO 982078 A NO982078 A NO 982078A NO 982078 L NO982078 L NO 982078L
- Authority
- NO
- Norway
- Prior art keywords
- compound
- transplantation
- piperazine
- aryl
- protecting
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- A61K38/166—Streptokinase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44014289A | 1989-11-22 | 1989-11-22 | |
PCT/EP1990/001985 WO1991007967A2 (en) | 1989-11-22 | 1990-11-19 | Method of preventing or limiting reperfusion damage |
SG118494A SG118494G (en) | 1989-11-22 | 1994-08-20 | Method of preventing or limiting reperfusion damage |
Publications (3)
Publication Number | Publication Date |
---|---|
NO982078L true NO982078L (no) | 1991-08-26 |
NO982078D0 NO982078D0 (no) | 1998-05-07 |
NO311701B1 NO311701B1 (no) | 2002-01-14 |
Family
ID=26664237
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO912511A NO304519B1 (no) | 1989-11-22 | 1991-06-26 | Fremstilling av (1)-(-)-2-(aminokarbonyl)-N-(4-amino-2,6-diklorfenyl)-4-[5,5-bis(4-fluorfenyl)pentyl]-1-piperazinacetamid |
NO19982078A NO311701B1 (no) | 1989-11-22 | 1998-05-07 | Fremgangsmåte for beskyttelse av et donorhjerte for transplantering samt anvendelse av en N-aryl-piperazinalkanamidforbindelse for dette formål |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO912511A NO304519B1 (no) | 1989-11-22 | 1991-06-26 | Fremstilling av (1)-(-)-2-(aminokarbonyl)-N-(4-amino-2,6-diklorfenyl)-4-[5,5-bis(4-fluorfenyl)pentyl]-1-piperazinacetamid |
Country Status (22)
Country | Link |
---|---|
EP (2) | EP0455789B1 (no) |
JP (1) | JP2574585B2 (no) |
KR (1) | KR0165686B1 (no) |
AT (2) | ATE102831T1 (no) |
AU (1) | AU632888B2 (no) |
CA (1) | CA2044143C (no) |
CY (1) | CY1869A (no) |
DE (2) | DE69007471T2 (no) |
DK (2) | DK0577171T3 (no) |
ES (2) | ES2053208T3 (no) |
FI (1) | FI109694B (no) |
HK (1) | HK115095A (no) |
HU (1) | HU215847B (no) |
IE (1) | IE65121B1 (no) |
IL (1) | IL96390A (no) |
NO (2) | NO304519B1 (no) |
NZ (1) | NZ236168A (no) |
PT (2) | PT95959B (no) |
RU (1) | RU2093156C1 (no) |
SG (1) | SG118494G (no) |
WO (1) | WO1991007967A2 (no) |
ZA (1) | ZA909345B (no) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9202266D0 (sv) * | 1992-07-31 | 1992-07-31 | Kabi Pharmacia Ab | Novel piperazine carboxamides |
SE9504661D0 (sv) | 1995-12-22 | 1995-12-22 | Astra Pharma Inc | New compounds |
US6683100B2 (en) | 1999-01-19 | 2004-01-27 | Novartis Ag | Organic compounds |
US6194181B1 (en) | 1998-02-19 | 2001-02-27 | Novartis Ag | Fermentative preparation process for and crystal forms of cytostatics |
SE9904674D0 (sv) | 1999-12-20 | 1999-12-20 | Astra Pharma Inc | Novel compounds |
SE9904673D0 (sv) | 1999-12-20 | 1999-12-20 | Astra Pharma Inc | Novel compounds |
SE0001209D0 (sv) | 2000-04-04 | 2000-04-04 | Astrazeneca Canada Inc | Novel compounds |
ES2319876T3 (es) | 2001-05-18 | 2009-05-14 | Astrazeneca Ab | Derivados de 4 (fenil-piperazinil-metil) benzamida y su uso para el tratamiento de la ansiedad o trastornos gastrointestinales. |
SE0203300D0 (sv) | 2002-11-07 | 2002-11-07 | Astrazeneca Ab | Novel Compounds |
SE0203302D0 (sv) | 2002-11-07 | 2002-11-07 | Astrazeneca Ab | Novel Compounds |
SE0203303D0 (sv) | 2002-11-07 | 2002-11-07 | Astrazeneca Ab | Novel Compounds |
CA2575975A1 (en) * | 2003-11-12 | 2005-05-26 | Dr. Reddy's Laboratories, Inc. | Preparation of escitalopram |
MX2007001240A (es) | 2004-08-02 | 2007-03-23 | Astrazeneca Ab | Derivados de diarilmetil-piperazina, preparaciones y usos de las mismas. |
FR2946340B1 (fr) | 2009-06-05 | 2011-06-24 | Galderma Res & Dev | Nouveaux n-phenyl acetamie, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant. |
KR101900124B1 (ko) | 2014-06-25 | 2018-09-18 | 전남대학교산학협력단 | 전복 박리용 조성물 |
KR101644299B1 (ko) | 2014-07-22 | 2016-08-02 | 주식회사 엔바이로젠 | 오미자 및 삼채 추출물을 유효성분으로 포함하는 전복 박리용 조성물 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4766125A (en) * | 1981-06-23 | 1988-08-23 | Janssen Pharmaceutica N.V. | N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia |
NZ223847A (en) * | 1987-04-01 | 1989-12-21 | Janssen Pharmaceutica Nv | Substituted piperazine derivatives and pharmaceutical compositions |
-
1990
- 1990-11-19 DK DK93201656T patent/DK0577171T3/da active
- 1990-11-19 ES ES90917677T patent/ES2053208T3/es not_active Expired - Lifetime
- 1990-11-19 DE DE69007471T patent/DE69007471T2/de not_active Expired - Fee Related
- 1990-11-19 AT AT90917677T patent/ATE102831T1/de not_active IP Right Cessation
- 1990-11-19 CA CA002044143A patent/CA2044143C/en not_active Expired - Fee Related
- 1990-11-19 KR KR1019910700758A patent/KR0165686B1/ko not_active IP Right Cessation
- 1990-11-19 WO PCT/EP1990/001985 patent/WO1991007967A2/en active IP Right Grant
- 1990-11-19 IL IL9639090A patent/IL96390A/en not_active IP Right Cessation
- 1990-11-19 EP EP90917677A patent/EP0455789B1/en not_active Expired - Lifetime
- 1990-11-19 AT AT93201656T patent/ATE213943T1/de not_active IP Right Cessation
- 1990-11-19 DK DK90917677.8T patent/DK0455789T3/da active
- 1990-11-19 AU AU68763/91A patent/AU632888B2/en not_active Ceased
- 1990-11-19 DE DE69033926T patent/DE69033926T2/de not_active Expired - Fee Related
- 1990-11-19 ES ES93201656T patent/ES2173883T3/es not_active Expired - Lifetime
- 1990-11-19 HU HU2436/91A patent/HU215847B/hu not_active IP Right Cessation
- 1990-11-19 EP EP19930201656 patent/EP0577171B1/en not_active Expired - Lifetime
- 1990-11-19 RU SU905001085A patent/RU2093156C1/ru active
- 1990-11-19 JP JP3500097A patent/JP2574585B2/ja not_active Expired - Fee Related
- 1990-11-20 NZ NZ236168A patent/NZ236168A/xx unknown
- 1990-11-21 ZA ZA909345A patent/ZA909345B/xx unknown
- 1990-11-21 IE IE420990A patent/IE65121B1/en not_active IP Right Cessation
- 1990-11-22 PT PT95959A patent/PT95959B/pt not_active IP Right Cessation
-
1991
- 1991-06-26 NO NO912511A patent/NO304519B1/no unknown
- 1991-07-16 FI FI913433A patent/FI109694B/fi active
-
1994
- 1994-08-20 SG SG118494A patent/SG118494G/en unknown
-
1995
- 1995-07-13 HK HK115095A patent/HK115095A/xx not_active IP Right Cessation
-
1996
- 1996-04-05 CY CY186996A patent/CY1869A/xx unknown
-
1998
- 1998-04-20 PT PT102145A patent/PT102145B/pt not_active IP Right Cessation
- 1998-05-07 NO NO19982078A patent/NO311701B1/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO982078D0 (no) | FremgangsmÕte for beskyttelse av et donorhjerte for transplantering samt anvendelse av en N-aryl-piperazinalkanamidforbindelse for dette formÕl | |
FI850078A0 (fi) | N-(4-piperidinyl)-bicykliska -kondenserade 2-imidazolaminderivat. | |
FI870421A0 (fi) | Analogiamenetelmä alkueläintenvastaisesti vaikuttavien 5,6-dihydro-2-(substituoitu fenyyli)-1,2,4-triatsiini-3,5(2H,4H)-dionijohdannaisten valmistamiseksi | |
DE68923169T2 (de) | Verwendung von fluor enthaltenden Pyridoncarbonsäure-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von HIV infektionen. | |
FI933719A0 (fi) | 4-((2-bensotiazolyl)metylamino)-a-((3,4-difluorfenoxi)metyl)-1-piperidinetanol | |
DE2960627D1 (en) | 2-(n-(2'chloro-4'-methyl-thienyl-3')-n-(cyclopropylmethyl)-amino) imidazoline (2), its acid addition salts, pharmaceutical preparations containing them and process for their preparation | |
DE68922605D1 (de) | Verfahren zur Herstellung von (-)2-(2-(2-Aminoethoxy)ethoxy)methyl)-4-(2,3-dichlorphenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridin, und Zwischenprodukt zu dessen Herstellung. |